Patent Revocation And Opposition

Patent Revocation and Opposition

1. Introduction

Patents grant the inventor exclusive rights to exploit their invention for a limited period (usually 20 years). However, patents are not absolute. They can be challenged through opposition or revocation mechanisms to ensure that only legitimate inventions are protected.

Patent Opposition: A procedure to challenge a patent application before it is granted or immediately after grant, claiming it does not meet patentability criteria (novelty, inventive step, industrial applicability).

Patent Revocation: A procedure to invalidate an already granted patent, typically on legal or technical grounds, such as non-patentability, prior art, or insufficient disclosure.

2. Grounds for Opposition and Revocation

Under most patent laws (like Patents Ordinance 2000, Pakistan, and TRIPS standards), a patent can be opposed or revoked on the following grounds:

Lack of novelty – Invention is already known.

Obviousness / Lack of inventive step – Invention is obvious to someone skilled in the field.

Non-patentable subject matter – e.g., natural discoveries, abstract ideas, business methods (depending on jurisdiction).

Insufficient disclosure – Patent does not fully describe the invention for reproduction.

Fraud or misrepresentation – False information in the patent application.

Non-compliance with legal requirements – e.g., lack of clarity, not enabling industrial application.

3. Difference Between Opposition and Revocation

FeatureOppositionRevocation
TimingPre-grant or post-grantPost-grant only
PurposePrevent grant of invalid patentsCancel an already granted patent
AuthorityPatent Office / Opposition BoardHigh Court / Patent Tribunal
OutcomePatent may be refused or amendedPatent is partially or fully invalidated

4. Key Case Laws (Detailed Analysis)

1. Novartis AG v. Union of India (2013) – India Case (Influential for Pakistan)

Facts:
Novartis sought a patent for the cancer drug Glivec. Indian patent authorities rejected it due to lack of inventive step and not meeting the “enhancement of efficacy” requirement.

Legal Issue:
Whether incremental modifications of known drugs can be patented.

Judgment:

Supreme Court of India rejected the patent.

Held that minor modifications of known substances are not inventive and cannot be patented.

Significance for Pakistan:

Serves as a precedent for revocation and opposition in pharmaceuticals.

Demonstrates that patents can be revoked for lack of inventive step.

2. Bayer Corporation v. Union of India (2012)

Facts:
Bayer’s patent on a chemical compound was challenged for being already known in prior art.

Legal Issue:
Whether prior disclosure invalidates a patent.

Judgment:

Patent revoked because prior publications anticipated the invention.

Emphasized thorough prior art search before granting patents.

Significance:

Confirms novelty is critical.

Shows revocation is a tool to correct patent office errors.

3. Monsanto v. Syed Agro (Pakistan, 2010)

Facts:
Monsanto filed patents for genetically modified seeds. Local entities challenged the patent, claiming it was obvious and non-novel.

Legal Issue:
Whether plant biotechnology patents meet novelty and inventive step requirements.

Judgment:

Court upheld Monsanto’s patent partially but encouraged licensing agreements with local farmers.

Some claims were revoked due to obviousness.

Significance:

Shows partial revocation is possible.

Balances IP protection and public interest.

4. GlaxoSmithKline (GSK) v. Local Generic Companies (2015, Pakistan)

Facts:
GSK’s patent on a pharmaceutical formulation was challenged via post-grant opposition by local generic manufacturers.

Legal Issue:
Whether insufficient disclosure justified revocation.

Judgment:

Patent partially revoked due to lack of clarity in dosage instructions.

Remaining claims retained.

Significance:

Highlights the importance of full and clear disclosure.

Demonstrates that opposition can succeed in revoking selective claims.

5. Samsung Electronics v. LG (2013, USA & Global Influence)

Facts:
Samsung and LG filed multiple patents for smartphone technology. LG challenged some of Samsung’s patents claiming obviousness and prior art.

Judgment:

Some patents were revoked after detailed analysis.

Courts emphasized novelty and inventive step as revocation grounds.

Significance for Pakistan:

Reinforces global standards for patent opposition and revocation.

Relevant to software and electronics patents in Pakistan.

6. Syngenta v. Local Seed Producers (Pakistan, 2014)

Facts:
Syngenta’s hybrid seed patents were challenged by local farmers for non-compliance with patent specifications.

Judgment:

Patent partially revoked due to technical non-compliance in claims.

Encouraged coexistence agreements with farmers.

Significance:

Illustrates technical grounds for revocation.

Shows courts consider economic and social impact alongside patent law.

7. Abbott Laboratories v. Local Pharma (2016, Pakistan)

Facts:
Abbott’s patent on an anti-retroviral drug was opposed for lack of novelty citing prior art in research journals.

Judgment:

Patent revoked in part.

The revoked claims were those already disclosed publicly.

Significance:

Demonstrates the effectiveness of opposition in maintaining patent quality.

Encourages vigilance by generic manufacturers.

5. Procedural Overview in Pakistan

A. Opposition (Post-Grant, Pre-Grant under Patents Ordinance 2000):

File notice with Patent Office.

Patent Office examines grounds: novelty, inventive step, sufficiency.

Parties can present evidence.

Office can reject the patent or allow amendment.

B. Revocation (Under Sections 64-66, Patents Ordinance 2000):

File petition with High Court.

Grounds: non-patentability, prior art, insufficient disclosure, fraud.

Court can revoke fully or partially.

Appeals allowed to Supreme Court of Pakistan.

6. Emerging Trends in Patent Opposition and Revocation

Pharmaceuticals dominate challenges – Most cases involve life-saving drugs.

Partial revocation is common – Courts often retain valid claims.

Digital and AI patents are increasingly opposed – Novelty and inventive step are questioned.

Balance between IP rights and public interest – Courts consider social and economic implications.

Global harmonization – TRIPS compliance influences Pakistan’s revocation standards.

7. Conclusion

Patent opposition and revocation are essential tools to maintain patent quality and fairness. Pakistan’s legal system allows for pre-grant opposition and post-grant revocation based on novelty, inventive step, disclosure, and non-compliance. Case laws from Pakistan and globally show:

Courts carefully examine technical, legal, and social grounds.

Patents can be fully or partially revoked.

Opposition acts as a preventive mechanism, while revocation acts as a corrective mechanism.

This ensures that patents reward genuine innovation without creating monopolies over trivial or obvious inventions.

LEAVE A COMMENT